In the journey from an early molecule of interest to the nomination of a development candidate, the abundance of tools and technologies available to biopharmaceutical researchers ultimately generates a complex landscape of information that requires careful review and analysis. These collaborative interactions represent a critical stage in the design and execution of a program plan that will ultimately result in the delivery of a medicine of value to patients.

Collaborative Pharma Consulting LLC (CPC, LLC) can provide guidance and decision-making frameworks to drive the ‘molecule to market’ process. Decisions made during the early stages of a project have significant impact on the progress of a therapeutic entity towards the clinic.